Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.

Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.

Show other versions (1)

<h4>Background</h4>Metastatic breast cancer (mBC) is a heterogenous disease with increasing availability of targeted therapies as well as emerging genomic markers of therapeutic resistance, necessitating timely and accurate molecular characterization of disease. As a minimally invasive t...

Full description

Bibliographic Details
Main Authors: Andjelija Zivanovic Bujak, Chen-Fang Weng, Maria João Silva, Miriam Yeung, Louisa Lo, Sarah Ftouni, Cassandra Litchfield, Yi-An Ko, Keilly Kuykhoven, Courtney Van Geelen, Sushma Chandrashekar, Mark A Dawson, Sherene Loi, Stephen Q Wong, Sarah-Jane Dawson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-10-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003363

Internet

https://doi.org/10.1371/journal.pmed.1003363

Similar Items